vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and Whitestone REIT (WSR). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $43.9M, roughly 1.4× Whitestone REIT). Whitestone REIT runs the higher net margin — 52.0% vs -70.9%, a 122.9% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs 7.5%). Whitestone REIT produced more free cash flow last quarter ($50.5M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 8.7%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Whitestone REIT is a publicly traded real estate investment trust that acquires, owns, manages and redevelops open-air community shopping centers, primarily located in high-growth metropolitan areas across the southwestern and southeastern United States. Its property portfolio is largely anchored by daily necessity, service-focused retail tenants that cater to regular local consumer demand.
CTKB vs WSR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $43.9M |
| Net Profit | $-44.1M | $22.8M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | 53.0% |
| Net Margin | -70.9% | 52.0% |
| Revenue YoY | 8.1% | 7.5% |
| Net Profit YoY | -557.1% | 31.7% |
| EPS (diluted) | — | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $43.9M | ||
| Q3 25 | $52.3M | $41.0M | ||
| Q2 25 | $45.6M | $37.9M | ||
| Q1 25 | $41.5M | $38.0M | ||
| Q4 24 | $57.5M | $40.8M | ||
| Q3 24 | $51.5M | $38.6M | ||
| Q2 24 | $46.6M | $37.6M | ||
| Q1 24 | $44.9M | $37.2M |
| Q4 25 | $-44.1M | $22.8M | ||
| Q3 25 | $-5.5M | $18.3M | ||
| Q2 25 | $-5.6M | $5.1M | ||
| Q1 25 | $-11.4M | $3.7M | ||
| Q4 24 | $9.6M | $17.3M | ||
| Q3 24 | $941.0K | $7.6M | ||
| Q2 24 | $-10.4M | $2.6M | ||
| Q1 24 | $-6.2M | $9.3M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | 53.0% | ||
| Q3 25 | -17.6% | 45.5% | ||
| Q2 25 | -23.3% | 13.8% | ||
| Q1 25 | -36.1% | 10.2% | ||
| Q4 24 | 5.2% | 43.3% | ||
| Q3 24 | -8.2% | 20.3% | ||
| Q2 24 | -18.3% | 7.2% | ||
| Q1 24 | -23.9% | 25.9% |
| Q4 25 | -70.9% | 52.0% | ||
| Q3 25 | -10.5% | 44.7% | ||
| Q2 25 | -12.2% | 13.3% | ||
| Q1 25 | -27.5% | 9.7% | ||
| Q4 24 | 16.8% | 42.5% | ||
| Q3 24 | 1.8% | 19.7% | ||
| Q2 24 | -22.4% | 6.9% | ||
| Q1 24 | -13.8% | 25.1% |
| Q4 25 | — | $0.43 | ||
| Q3 25 | — | $0.35 | ||
| Q2 25 | — | $0.10 | ||
| Q1 25 | — | $0.07 | ||
| Q4 24 | — | $0.34 | ||
| Q3 24 | — | $0.15 | ||
| Q2 24 | — | $0.05 | ||
| Q1 24 | — | $0.18 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $4.9M |
| Total DebtLower is stronger | — | $649.4M |
| Stockholders' EquityBook value | $341.7M | $458.1M |
| Total Assets | $461.5M | $1.2B |
| Debt / EquityLower = less leverage | — | 1.42× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $4.9M | ||
| Q3 25 | $93.3M | $6.8M | ||
| Q2 25 | $75.5M | $5.3M | ||
| Q1 25 | $95.3M | $5.6M | ||
| Q4 24 | $98.7M | $5.2M | ||
| Q3 24 | $162.3M | $2.5M | ||
| Q2 24 | $177.9M | $3.2M | ||
| Q1 24 | $168.8M | $6.2M |
| Q4 25 | — | $649.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $632.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $341.7M | $458.1M | ||
| Q3 25 | $378.6M | $439.5M | ||
| Q2 25 | $377.6M | $427.5M | ||
| Q1 25 | $379.6M | $431.0M | ||
| Q4 24 | $395.7M | $438.2M | ||
| Q3 24 | $385.5M | $419.5M | ||
| Q2 24 | $389.1M | $418.3M | ||
| Q1 24 | $392.6M | $421.6M |
| Q4 25 | $461.5M | $1.2B | ||
| Q3 25 | $494.9M | $1.1B | ||
| Q2 25 | $493.3M | $1.2B | ||
| Q1 25 | $482.6M | $1.1B | ||
| Q4 24 | $499.5M | $1.1B | ||
| Q3 24 | $491.2M | $1.1B | ||
| Q2 24 | $483.7M | $1.1B | ||
| Q1 24 | $492.1M | $1.1B |
| Q4 25 | — | 1.42× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.44× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $50.8M |
| Free Cash FlowOCF − Capex | $-1.8M | $50.5M |
| FCF MarginFCF / Revenue | -2.9% | 114.9% |
| Capex IntensityCapex / Revenue | 1.6% | 0.7% |
| Cash ConversionOCF / Net Profit | — | 2.22× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $50.8M | ||
| Q3 25 | $-3.9M | $18.0M | ||
| Q2 25 | $108.0K | $13.8M | ||
| Q1 25 | $-125.0K | $3.1M | ||
| Q4 24 | $2.0M | $58.2M | ||
| Q3 24 | $13.2M | $16.4M | ||
| Q2 24 | $6.2M | $12.3M | ||
| Q1 24 | $4.0M | $11.5M |
| Q4 25 | $-1.8M | $50.5M | ||
| Q3 25 | $-4.6M | — | ||
| Q2 25 | $-1.5M | — | ||
| Q1 25 | $-974.0K | — | ||
| Q4 24 | $1.1M | $58.0M | ||
| Q3 24 | $12.2M | — | ||
| Q2 24 | $5.2M | — | ||
| Q1 24 | $3.4M | — |
| Q4 25 | -2.9% | 114.9% | ||
| Q3 25 | -8.7% | — | ||
| Q2 25 | -3.2% | — | ||
| Q1 25 | -2.3% | — | ||
| Q4 24 | 1.9% | 142.1% | ||
| Q3 24 | 23.7% | — | ||
| Q2 24 | 11.0% | — | ||
| Q1 24 | 7.6% | — |
| Q4 25 | 1.6% | 0.7% | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 3.5% | — | ||
| Q1 25 | 2.0% | — | ||
| Q4 24 | 1.6% | 0.5% | ||
| Q3 24 | 2.0% | — | ||
| Q2 24 | 2.3% | — | ||
| Q1 24 | 1.3% | — |
| Q4 25 | — | 2.22× | ||
| Q3 25 | — | 0.98× | ||
| Q2 25 | — | 2.74× | ||
| Q1 25 | — | 0.83× | ||
| Q4 24 | 0.21× | 3.36× | ||
| Q3 24 | 14.05× | 2.15× | ||
| Q2 24 | — | 4.73× | ||
| Q1 24 | — | 1.23× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
WSR
Segment breakdown not available.
